SLU-PP-332
£47.76
Description
What is SLU-PP-332?
SLU-PP-332 is a synthetic metabolic peptide that acts as a pan-agonist for estrogen-related receptors (ERRα, ERRβ, and ERRγ). It may enhance mitochondrial function, increase energy expenditure, and promote fatty acid oxidation, mimicking the benefits of exercise.
Studies suggest that it may help treat metabolic disorders by reducing fat accumulation and improving insulin sensitivity. However, this product is intended for research use only and is not for human or veterinary use.
Product Name | Slu-PP-332 |
CAS Number | 303760-60-3 |
Molar Mass | 290.32 g/mol |
Chemical Formula | C18H14N2O2 |
IUPAC Name | (E)-4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide |
How does SLU-PP-332 work?
- SLU-PP-332 is believed to interact with cellular signaling pathways, potentially influencing energy metabolism and cellular stress responses.
- Preliminary studies suggest it may target key proteins involved in metabolic regulation.
- Researchers are exploring its effects on mitochondrial function and its role in cellular adaptation mechanisms.
Potential Benefits of SLU-PP-332
SLU-PP-332 may offer several potential benefits including:
- It may support research into metabolic pathways and cellular efficiency.
- It is known for potential applications in energy regulation studies.
- It could assist in research on cellular longevity and stress responses.
- It may provide insights into advanced biological functions and nutrient processing.
- Useful in research focusing on cellular health and metabolic optimization.
Note: This product is intended for research purposes and is not approved for human use.
SLU-PP-332 and Metabolic Disorders
SLU-PP-332 is being studied for its potential role in metabolic disorders by activating estrogen-related receptors (ERRs). It may enhance mitochondrial function, increase energy expenditure, and promote fat oxidation. This may help combat obesity and insulin resistance.
Preclinical studies have shown reduced fat accumulation and improved insulin sensitivity, suggesting its possible use in managing metabolic diseases.
Clinical Research
While SLU-PP-332 is still under investigation, preliminary studies have shown multiple potential benefits. It may help with metabolic disorders and energy regulation, and support mitochondrial function. It also has potential applications in aging-related research.
More clinical trials to evaluate its long-term benefits and efficacy.
Reviews
There are no reviews yet.